Therapeutics Acquisition Corp.
RACA News Today: Stay Updated with the Latest Therapeutics Acquisition Corp. News in Real Time
Find RACA news now at Meyka AI. Stay informed with the latest Therapeutics Acquisition Corp. stocks updates, including price news, market analysis, and expert insights.

APP.CN Stock Crashes 50% as Compliance Tech Firm Faces Steep Decline
APP.CN stock plummets 50% to C$0.005 on May 21, 2026. Global Compliance Applications Corp. faces severe headwinds in blockchain and ESG tech.

Octanex Limited (OXX.AX) Trades at A$0.006 Amid Gold Exploration Focus
OXX.AX stock trades at A$0.006 with 59x volume spike. Octanex Limited explores gold in Western Australiaβs Eastern Goldfields.

Silexion Therapeutics Stock Surges 97% on Phase 2/3 Trial Approval
SLXN stock jumps 97% after Israeli health ministry approves Phase 2/3 pancreatic cancer trial. Clinical milestone drives biotech rally.

Revive Therapeutics Surges 33% on Clinical Pipeline Momentum
RVV.CN stock jumps 33% as Revive Therapeutics advances rare disease and psychedelic drug candidates. Market cap reaches C$17.4M.

NECA Stock Surges 48,400% as New America Energy Gains Momentum
NECA stock jumps 48,400% to $0.0485 on pink sheets. New America Energy Corp. title loan business shows extreme volatility.

PGR Maintained at Buy by BofA Securities, May 2026
Bank of America Securities maintained PGR at Buy with price target lowered to $320. BMO Capital holds Market Perform rating with $220 target.

Trial Holdings May 21: Seiyu Acquisition Sparks Retail Debate
Trial Holdings denies Seiyu acquisition reports, addresses employee treatment concerns and pricing strategy feedback.

Ceres Global Ag Corp. Stock Bounces Back as Grain Sector Stabilizes
CRP.TO stock recovers from oversold levels as agricultural commodity demand strengthens. Current price C$6.11 with strong year-to-date gains.

Optimi Health Corp. Surges 2,361% as OPTI.CN Files $20M Nasdaq IPO
OPTI.CN stock surges 2,361% to C$8.0 as Optimi Health files $20M US IPO on Nasdaq. Functional mushroom company targets expansion.